Stock Track | Sino Biopharm Shares Soar on Subsidiary's Share Buyback

Stock Track10-04

Shares of Sino Biopharmaceutical Ltd. (HKG:1177), a leading biopharmaceutical company in China, surged by 7.25% on October 4, 2024, closing at a high of HK$4.15 per share.

The rally in Sino Biopharm's stock price came on the heels of news that its subsidiary, Chia Tai Tianqing Pharmaceutical, had been actively purchasing shares of the company under a share award scheme. According to a filing with the Hong Kong Stock Exchange, Chia Tai Tianqing acquired 187,385,000 shares of Sino Biopharm from May 7 to September 30, 2024, for a total consideration of HK$550.6 million.

The share buyback program, which is aimed at rewarding employees and aligning their interests with those of shareholders, is seen as a vote of confidence in Sino Biopharm's future prospects. By repurchasing its own shares, the company reduces the number of outstanding shares, effectively increasing the ownership stake of existing shareholders and potentially boosting earnings per share.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1178387375?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-04 17:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1178387375","market":"hk","top_or_hot":-1,"title":"Stock Track | Sino Biopharm Shares Soar on Subsidiary's Share Buyback","media":"Stock Track","content":"<p>Shares of Sino Biopharmaceutical Ltd. (HKG:1177), a leading biopharmaceutical company in China, surged by 7.25% on October 4, 2024, closing at a high of HK$4.15 per share.</p>\n\n<p>The rally in Sino Biopharm's stock price came on the heels of news that its subsidiary, Chia Tai Tianqing Pharmaceutical, had been actively purchasing shares of the company under a share award scheme. According to a filing with the Hong Kong Stock Exchange, Chia Tai Tianqing acquired 187,385,000 shares of Sino Biopharm from May 7 to September 30, 2024, for a total consideration of HK$550.6 million.</p>\n\n<p>The share buyback program, which is aimed at rewarding employees and aligning their interests with those of shareholders, is seen as a vote of confidence in Sino Biopharm's future prospects. By repurchasing its own shares, the company reduces the number of outstanding shares, effectively increasing the ownership stake of existing shareholders and potentially boosting earnings per share.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Sino Biopharm Shares Soar on Subsidiary's Share Buyback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Sino Biopharm Shares Soar on Subsidiary's Share Buyback\n</h2>\n\n<h4 class=\"meta\">\n\n2024-10-04 17:58 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Sino Biopharmaceutical Ltd. (HKG:1177), a leading biopharmaceutical company in China, surged by 7.25% on October 4, 2024, closing at a high of HK$4.15 per share.\nThe rally in Sino Biopharm's...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01177","symbol_name":"中国生物制药","start_time":0,"source_url":"","article_id":"1178387375","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1178387375","pubTimestamp":1728035920,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Sino Biopharmaceutical Ltd. , a leading biopharmaceutical company in China, surged by 7.25% on October 4, 2024, closing at a high of HK$4.15 per share.The rally in Sino Biopharm's stock price came on the heels of news that its subsidiary, Chia Tai Tianqing Pharmaceutical, had been actively purchasing shares of the company under a share award scheme. According to a filing with the Hong Kong Stock Exchange, Chia Tai Tianqing acquired 187,385,000 shares of Sino Biopharm from May 7 to Sept","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01177":"中国生物制药"},"translate_title":"股票赛道中国生物制药股价因子公司回购股票而飙升","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01177":1},"content_text":"Shares of Sino Biopharmaceutical Ltd. (HKG:1177), a leading biopharmaceutical company in China, surged by 7.25% on October 4, 2024, closing at a high of HK$4.15 per share.\nThe rally in Sino Biopharm's stock price came on the heels of news that its subsidiary, Chia Tai Tianqing Pharmaceutical, had been actively purchasing shares of the company under a share award scheme. According to a filing with the Hong Kong Stock Exchange, Chia Tai Tianqing acquired 187,385,000 shares of Sino Biopharm from May 7 to September 30, 2024, for a total consideration of HK$550.6 million.\nThe share buyback program, which is aimed at rewarding employees and aligning their interests with those of shareholders, is seen as a vote of confidence in Sino Biopharm's future prospects. By repurchasing its own shares, the company reduces the number of outstanding shares, effectively increasing the ownership stake of existing shareholders and potentially boosting earnings per share.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1178387375"}